Holds one active US DMF and one valid CEP for cefixime, filing since 2013. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF and one valid CEP for cefixime, filing since 2006. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for cefixime, filing since 2002. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds one active US DMF and 2 valid CEPs for cefixime, filing since 2012. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for cefixime, filing since 2006. Its GMP is recognised in 6 markets.
Holds one active US DMF for cefixime, filing since 2012. Its GMP is recognised in 5 markets.
Holds one active US DMF for cefixime, filing since 2010. Its 2015 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Registered with SFDA (Saudi Arabia) for cefixime. Its GMP is recognised in 3 markets.
Registered with SFDA (Saudi Arabia) for cefixime. Its GMP is recognised in 2 markets.
Registered with PMDA (Japan) for cefixime.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Cefixime manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free